Rayence Co

Rayence Co Rule of 40

The Rule of 40 of Rayence Co (228850.KQ) as of Oct 23, 2026 is -12.08 %. In the previous year, Rule of 40 was -6.90 % — a change of 74.95% (lower).

Rule of 40

-12.08 %

YoY

74.95%

Last updated:

Rule of 40 of Rayence Co is 2025 -12.08 % . Rule of 40 of Rayence Co was 2024 -6.90 % . It decreases by 74.95% lower compared to the previous year.

The Rayence Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
25.05 KRW
Jan 1, 2019
23.61 KRW
Jan 1, 2020
-17.95 KRW
Jan 1, 2021
47.76 KRW
Jan 1, 2022
24.33 KRW
Jan 1, 2023
10.69 KRW
Jan 1, 2024
-6.90 KRW
Jan 1, 2025
-12.08 KRW
The Rayence Co Rule of 40 history
YEARRule of 40YoY
-12.08 %+74.95%
-6.90 %-164.56%
10.69 %-56.05%
24.33 %-49.06%
47.76 %-366.03%
-17.95 %-176.02%
23.61 %-5.71%
25.05 %+2.53%
24.43 %-23.51%
31.94 %-5.77%
33.89 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rayence Co stock

Rule of 40 of Rayence Co is -12.08 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Rayence Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Rayence Co

All Key Metrics — Rayence Co